Taylor A, Milton W, Christian P E, Datz F L, Joyce L, DeVries W C
Clin Nucl Med. 1985 Jun;10(6):427-31. doi: 10.1097/00003072-198506000-00012.
On December 2, 1982, a permanent total artificial heart was implanted into the chest of a 61-year-old man with a progressive and irreversible cardiomyopathy. During the ensuing four-month hospitalization, a number of nuclear medicine procedures were obtained to assist in patient management. These procedures included gated cardiac radionuclide ventriculography, an I-123 iodoamphetamine scan for cerebral perfusion, and In-111 labeled leukocyte imaging. These radionuclide studies demonstrate the advantages of being able to monitor physiologic changes noninvasively and illustrate a potential role for nuclear cardiology in managing patients with a total artificial heart.
1982年12月2日，一颗永久性全人工心脏被植入一名患有进行性不可逆心肌病的61岁男性的胸腔。在随后为期四个月的住院期间，进行了多项核医学检查以辅助患者治疗。这些检查包括门控心脏放射性核素心室造影、用于脑灌注的I-123碘安非他明扫描以及铟-111标记的白细胞显像。这些放射性核素研究证明了能够无创监测生理变化的优势，并说明了核心脏病学在全人工心脏患者管理中的潜在作用。
